← Eichor
Study identifier: NCT06993558 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Analysis of Safety and Tissue Interaction of Injectable Biosmulators

Condition: This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers  ·  Sponsor: Universitätsklinikum Hamburg-Eppendorf

PhaseNA
Planned participants90
Who can joinAll sexes, 30 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this clinical trial is to analyse tissue changes in the pre-auricular region after injectable (Poly-L-Lactic-Acid/Calcium-Hydroxylapatit) biostimulatory interventions in healthy volunteers. The main questions it aims to answer are: How is the Safety Profile of injectable Biostimulatory Treatments? How are the Tissue Interactions after injectable Biostiomulatory Treatments? Participants will: * Recieve one of 2 possible biostumulatory treatments (PLLA/CAHA/ * Attend 4 follow-up appointments after treatment for checkups, surveillance and examinations.

This description comes directly from the study's public registry record.

Talk to the study team

Lynhda Nguyen, M.D.  ·  +49 40 7410 - 54289  ·  l.nguyen@uke.de

Katarina Herberger, MD. PHD.  ·  +49 40 7410 - 54289  ·  k.herberger@uke.de

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Hamburg EppendorfHamburg, Free and Hanseatic City of Hamburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06993558